Amphenol Cl A saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 93 to 97.
Lean How — And When — To Sell Stocks
The new score means the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria. The market's biggest winners often have a 95 or higher score in the early stages of a new price run, so that's a good item to have on your checklist when looking for the best stocks to buy and watch.
Amphenol Cl A is currently forming a cup without handle, with a 79.39 buy point. See if the stock can break out in volume at least 40% above average.
The stock earns a 97 EPS Rating, meaning its recent quarterly and annual earnings growth tops 97% of all stocks.
Its Accumulation/Distribution Rating of C shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
The company reported a 58% increase in earnings for Q1. That means it's now posted seven straight quarters of rising EPS gains. Revenue growth climbed 48%, up from 30% in the prior report. The company has now posted accelerating growth in each of the last six reports.
Amphenol Cl A holds the No. 1 rank among its peers in the Electronics-Parts industry group. Park Aerospace and TE Connectivity are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
